Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.39 is 93% above its 5-year average of -19.50, near the high end of its 5-year range (-62.06–0.02).
82.23% below its 12-month average of -0.76.
Reported quarterly EPS; no daily interpolation. Q1 FY2027 (2026-06-30): -0.05.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 34 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T20:15:19.775Z. Historical observations retain their original dates. Historical series through 2025-11-05.
EARNINGS PER SHARE (EPS)
-1.39
EARNINGS PER SHARE (EPS) AVG TTM
-0.76
EARNINGS PER SHARE (EPS) AVG 3Y
-0.82
EARNINGS PER SHARE (EPS) AVG 5Y
-19.50
EARNINGS PER SHARE (EPS) AVG 10Y
-36.61
EARNINGS PER SHARE (EPS) AVG 15Y
-6.31
EARNINGS PER SHARE (EPS) AVG 20Y
-3.09
CURRENT VS TTM AVG
-82.23%
CURRENT VS 3Y AVG
-68.68%
CURRENT VS 5Y AVG
+92.87%
CURRENT VS 10Y AVG
+96.20%
CURRENT VS 15Y AVG
+77.98%
CURRENT VS 20Y AVG
+54.97%
Aurora Cannabis Inc.
Market Cap
$284.31M
Earnings Per Share (EPS)
-1.39
TTM Avg
-0.76
3Y Avg
-0.82
5Y Avg
-19.50
Market Cap
$285.42M
Earnings Per Share (EPS)
-1.28
TTM Avg
-1.52
3Y Avg
-1.49
5Y Avg
-1.26
Market Cap
$285.55M
Earnings Per Share (EPS)
-1.11
TTM Avg
-0.10
3Y Avg
-2.07
5Y Avg
-8.75
Market Cap
$282.64M
Earnings Per Share (EPS)
-0.23
TTM Avg
-0.20
3Y Avg
-1.19
5Y Avg
-1.02
Market Cap
$281.54M
Earnings Per Share (EPS)
-1.21
TTM Avg
-0.67
3Y Avg
-1.32
5Y Avg
-1.70
Market Cap
$280.37M
Earnings Per Share (EPS)
N/A
TTM Avg
-2880.36
3Y Avg
-1920.24
5Y Avg
-1440.18
Market Cap
$288.79M
Earnings Per Share (EPS)
-1.99
TTM Avg
-1.79
3Y Avg
-1.44
5Y Avg
-2.04
Market Cap
$292.59M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.02
3Y Avg
-0.02
5Y Avg
-0.02
Market Cap
$293.30M
Earnings Per Share (EPS)
-6.97
TTM Avg
-33.27
3Y Avg
-41.62
5Y Avg
-70.95
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aurora Cannabis Inc. (ACB) | $284.31M | -1.39 | -0.76 | -0.82 | -19.50 |
| Sagimet Biosciences Inc. (SGMT)vs › | $285.42M | -1.28 | -1.52 | -1.49 | -1.26 |
| Abeona Therapeutics Inc. (ABEO)vs › | $285.55M | -1.11 | -0.10 | -2.07 | -8.75 |
| Standard BioTools Inc. (LAB)vs › | $282.64M | -0.23 | -0.20 | -1.19 | -1.02 |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $281.54M | -1.21 | -0.67 | -1.32 | -1.70 |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $280.37M | N/A | -2880.36 | -1920.24 | -1440.18 |
| Larimar Therapeutics, Inc. (LRMR)vs › | $288.79M | -1.99 | -1.79 | -1.44 | -2.04 |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $292.59M | N/A | -0.02 | -0.02 | -0.02 |
| Indaptus Therapeutics, Inc. (INDP)vs › | $293.30M | -6.97 | -33.27 | -41.62 | -70.95 |
| Vanda Pharmaceuticals Inc. (VNDA)vs › | $271.81M | -4.63 | -2.03 | -0.98 | -0.48 |
Trailing EPS (TTM)
$-1.39
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2026-03-31 | -1.55 |
| 2025-03-31 | 0.02 |
| 2024-03-31 | -0.95 |
| 2022-06-30 | -62.06 |
| 2021-06-30 | -32.99 |
| 2020-06-30 | -245.93 |
| 2019-06-30 | -28.00 |
| 2018-06-30 | 13.70 |
| 2017-06-30 | -4.30 |
| 2016-06-30 | -4.11 |
| 2015-06-30 | -7.90 |
| 2014-06-30 | -15.24 |
| 2013-06-30 | -0.28 |
| 2012-06-30 | -0.24 |
| 2011-06-30 | -0.25 |
| 2010-06-30 | -0.03 |
| 2009-06-30 | -0.10 |
| 2008-06-30 | -0.19 |
| 2007-06-30 | 0.01 |
